NEUROSCIENCE. The unknowns of cognitive enhancement.
Department of Psychology, University of Pennsylvania, Philadelphia, PA 19104, USA. mfarah@psych.upenn.edu.
Martha J
MJ
Farah
D019969:Amphetamine-Related Disorders / Q000453:epidemiology / Q000523:psychology; D000662:Amphetamines / Q000008:administration & dosage / Q000009:adverse effects; D001559:Benzhydryl Compounds / Q000008:administration & dosage / Q000009:adverse effects; D024803:Biomedical Enhancement / Q000379:methods*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000009:adverse effects; D003071:Cognition / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D000077408:Modafinil; D009488:Neurosciences; D017397:Prefrontal Cortex / Q000187:drug effects / Q000502:physiology; D065908:Transcranial Direct Current Stimulation / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods; D064690:Wakefulness-Promoting Agents / Q000008:administration & dosage / Q000009:adverse effects
C090411:Adderall; D000662:Amphetamines; D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D064690:Wakefulness-Promoting Agents; D000077408:Modafinil